Working… Menu

A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal Melanoma (SUAVE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01551459
Recruitment Status : Completed
First Posted : March 12, 2012
Last Update Posted : October 29, 2019
Cancer Research UK
Information provided by (Responsible Party):
The Clatterbridge Cancer Centre NHS Foundation Trust

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 2017
Actual Study Completion Date : November 2017